Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan's inflation tops 2% in April, boosted by higher food prices
05/07/2025 09:30 PM - Politics
Taiwan at center of 'one-theater' defense concept: Former Japanese general
05/07/2025 09:12 PM - Society
Ministry halts plan to open 6 jobs categories to foreign students
05/07/2025 07:42 PM - Society
Kaohsiung court sentences 7 over attempted human smuggling
05/07/2025 07:21 PM - Business